Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Epidemiology of multiple sclerosis].
[Neuroprotective effect screening and the mechanism of 10 kinds of coumarin derivatives].
Olfactory Ensheathing Cell Transplantation after a Complete Spinal Cord Transection Mediates Neuroprotective and Immunomodulatory Mechanisms to Facilitate Regeneration.
A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.
"Her illness is a project we can work on together": developing a collaborative family-centered intervention model for newly diagnosed multiple sclerosis.
Control of microglial neurotoxicity by the fractalkine receptor.
Is there a (host) genetic predisposition to progressive multifocal leukoencephalopathy?
CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.
Cost Offset Analysis of Interferon Beta Disease Modifying Therapies In Relapsing-Remitting Multiple Sclerosis.
Misfiring in multiple sclerosis: Cerebellar Channelopathy, a Potential Novel Target?
Decreased NAA in Gray Matter is Correlated with Decreased Availability of Acetate in White Matter in Postmortem Multiple Sclerosis Cortex.
[Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
P2X7 Receptor as a Therapeutic Target.
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
Distinct T cell signatures define subsets of patients with multiple sclerosis.
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.
Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
Mouse Hepatitis Virus infection remodels Connexin43 mediated gap junction intercellular communication both in vitro and in vivo.
[Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con.]
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
DEMYELINATION/REMYELINATION AND EXPRESSION OF INTERLEUKIN-1β, SUBSTANCE P, NERVE GROWTH FACTOR, AND GLIAL-DERIVED NEUROTROPHIC FACTOR DURING TRIGEMINAL NEUROPATHIC PAIN IN RATS.
Pages
« first
‹ previous
…
671
672
673
674
675
676
677
678
679
…
next ›
last »